Ling Yang
Chairman bei ADICON HOLDINGS LIMITED
Profil
Ling Yang is currently the Chairman at Hangzhou Adicon Clinical Laboratories, Inc., the Non-Executive Chairman at ADICON Holdings Ltd., the Non-Executive Director at HUTCHMED (China) Ltd., and the Managing Director at Carlyle Asia Investment Advisors Ltd.
Ms. Yang is also a Non-Executive Director at Ambio Pharmaceuticals and holds positions as a Director at Ambio, Inc. and a Member at The Phi Beta Kappa Society.
Ms. Yang's former positions include being a Director at Shenzhen Salubris Pharmaceuticals Co., Ltd.
and Ambio Holdings, Inc., as well as a Vice President & Managing Director at The Carlyle Group, Inc. Ms. Yang was also a Principal at KKR Asia Ltd.
and Kohlberg Kravis Roberts & Co.(Beijing), and an Associate at The Carlyle Group, Inc. Ms. Yang completed an undergraduate degree at Smith College in 2002 and obtained an MBA from Harvard Business School in 2008.
Aktive Positionen von Ling Yang
| Unternehmen | Position | Beginn |
|---|---|---|
| ADICON HOLDINGS LIMITED | Chairman | 12.10.2018 |
| HUTCHMED (CHINA) LIMITED | Director/Board Member | 13.07.2023 |
| Carlyle Asia Investment Advisors Ltd. | Private Equity Investor | 01.01.2011 |
Hangzhou Adicon Clinical Laboratories, Inc.
 Hangzhou Adicon Clinical Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Hangzhou Adicon Clinical Laboratories, Inc. provides healthcare testing services. The private company is based in Hangzhou, China. | Chairman | 01.09.2018 |
Ambio Pharmaceuticals
 Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | Director/Board Member | 08.10.2020 |
Ambio, Inc.
 Ambio, Inc. Miscellaneous Commercial ServicesCommercial Services Ambio, Inc. is an American company that provides a platform for searching, comparing, requesting, and purchasing sustainable plastics from top material distributors and manufacturers. The private company is based in SC. The company's platform allows customers to quickly and easily find recycled and bio-based plastic materials at competitive prices, while also saving time by handling the search and logistics from start to finish. | Director/Board Member | - |
The Phi Beta Kappa Society
 The Phi Beta Kappa Society Miscellaneous Commercial ServicesCommercial Services The Phi Beta Kappa Society operates as an organization for liberal arts and science education. The non-profit company is based in Washington. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Ling Yang
| Unternehmen | Position | Ende |
|---|---|---|
KKR Asia Ltd.
 KKR Asia Ltd. Investment ManagersFinance Part of KKR & Co., Inc., KKR Asia Ltd. is a Chinese company. 'The private company is based in Hong Kong, Hong Kong. The company was founded in 2001. Zheng Sun has been the CEO of the company since 2007. | Corporate Officer/Principal | 01.02.2011 |
| Kohlberg Kravis Roberts & Co.(Beijing) | Private Equity Investor | 01.01.2011 |
| ░░░ ░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░ ░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Ling Yang
| Smith College | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| HUTCHMED (CHINA) LIMITED | Health Technology |
| SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. | Health Technology |
| THE CARLYLE GROUP INC. | Finance |
| ADICON HOLDINGS LIMITED | Health Services |
| Private Unternehmen | 8 |
|---|---|
The Phi Beta Kappa Society
The Phi Beta Kappa Society Miscellaneous Commercial ServicesCommercial Services The Phi Beta Kappa Society operates as an organization for liberal arts and science education. The non-profit company is based in Washington. | Commercial Services |
KKR Asia Ltd.
KKR Asia Ltd. Investment ManagersFinance Part of KKR & Co., Inc., KKR Asia Ltd. is a Chinese company. 'The private company is based in Hong Kong, Hong Kong. The company was founded in 2001. Zheng Sun has been the CEO of the company since 2007. | Finance |
Ambio Holdings, Inc.
 Ambio Holdings, Inc. Pharmaceuticals: MajorHealth Technology Ambio Holdings, Inc. operates as a pharmaceutical company which focuses on complex peptides. It develops processes for manufacturing peptides at small to large scale as active pharmaceutical ingredients used in New Chemical Entities and generic peptides by clients worldwide. The company was founded by Chris J. Bai in 2014 and is headquartered in North Augusta, SC. | Health Technology |
| Carlyle Asia Investment Advisors Ltd. | Finance |
Hangzhou Adicon Clinical Laboratories, Inc.
Hangzhou Adicon Clinical Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Hangzhou Adicon Clinical Laboratories, Inc. provides healthcare testing services. The private company is based in Hangzhou, China. | Commercial Services |
| Kohlberg Kravis Roberts & Co.(Beijing) | Finance |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | Commercial Services |
Ambio, Inc.
Ambio, Inc. Miscellaneous Commercial ServicesCommercial Services Ambio, Inc. is an American company that provides a platform for searching, comparing, requesting, and purchasing sustainable plastics from top material distributors and manufacturers. The private company is based in SC. The company's platform allows customers to quickly and easily find recycled and bio-based plastic materials at competitive prices, while also saving time by handling the search and logistics from start to finish. | Commercial Services |
